Scholars Central

Case reportPublished 31 May 2022

Pseudocirrhosis in Metastatic Breast Cancer in a Male Successfully Treated with Leuprorelin and Anastrozole Followed by Eribulin: A Case Report

Authors: Hafez Golzarian, Morgan Turnow, Alaha Mariam, Sidra R. Shah, Syed H. Haq, Benjamin A. Pasley, Christopher J. Hawkins, Rajpal Aujla, Joseph J. Sreenan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: There are very few studies and cases in the literature describing metastatic breast cancer in the male population, accounting for less than one percent of all cases. Of those who have been reported, the vast majority fail to survive beyond five years from time of diagnosis. The lack of literature in this population makes it difficult for clinicians to foresee and prepare for upcoming complications in management. One of the more serious complications in managing metastatic breast cancer is the development of pseudocirrhosis, a frequent long-term side effect of chemotherapy and/or radiation typically seen in patients with malignancy in the liver. Case Presentation: We report the case of a 48-year-old male with a completely unremarkable family, medical, and social history other than a homozygous mutation in his MTHFR gene who was diagnosed with stage IV ER/PR-positive, HER-2/neu negative, BRCA1 and BRCA2-negative breast cancer with metastasis to bone, lung, and liver. He was successfully treated with an initial regimen consisting of radiation, Denosumab, Leuprorelin, and Anastrozole. After completing five years of hormone therapy, he was initiated on Eribulin. Eight years since time of diagnosis, he continues to survive and undergo symptomatic management of long-term side-effects of his treatments. Conclusions: To our knowledge this is the only reported case of metastatic breast cancer with pseudocirrhosis in a male patient. It is imperative to report this unique case to help increase awareness for clinicians managing other males with breast cancer. What makes this case even more reportable is the good outcome overall as our patient remains alive and well eight years since time of diagnosis, a relatively difficult and rare feat to achieve in end-stage breast cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Oncology: Case Reports.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Oncology: Case Reports
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Hafez Golzarian”
  • BylineArticles whose byline prints “Morgan Turnow”
  • BylineArticles whose byline prints “Alaha Mariam”
  • BylineArticles whose byline prints “Sidra R. Shah”
  • BylineArticles whose byline prints “Syed H. Haq”
  • BylineArticles whose byline prints “Benjamin A. Pasley”
  • BylineArticles whose byline prints “Christopher J. Hawkins”
  • BylineArticles whose byline prints “Rajpal Aujla”